Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $175.00.

Investors might want to bet on Co-Diagnostics, Inc. (CODX), as it has ... A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate ...

pence - 'neutral' Barclays raises Anglo American price target to 3,000 (2,820) pence - 'overweight' Barclays raises Bunzl to 'overweight' - price target 3,650 pence Jefferies raises Softcat price ...

Side Quest is now streaming on Apple TV+. Over the course of four seasons (the most recent of which just ended), Mythic Quest has built a fully realized, ripe-for-exploration universe around the ...

Barclays this week propelled its view on the Financials (NYSEARCA:XLF) sector, setting its sights partially on what’s considered to be a looser regulatory environment in Washington. The S&P 500 ...

March 27 (Reuters) - Barclays said on Thursday it favors fixed income investments over equities for the first time in "several quarters" and warned global economic growth was at risk due to U.S ...

Barclays strategist Venu Krishna slashed his 2025 S&P 500 (^GSPC) price target to 5,900 from 6,600 on Wednesday, citing tariffs and "deteriorating" economic data. The S&P 500 currently sits at ...

March 26 (Reuters) - Barclays on Wednesday became the latest brokerage after Goldman Sachs and RBC Capital Markets to slash its year-end target for the benchmark S&P 500 index, due to uncertainty ...

On Monday, Barclays adjusted its stance on SBM Offshore NV shares, downgrading the company’s stock rating from Overweight to Equal Weight. The new price target has been set at EUR25.00.

Barclays upped their price target on shares of Quest Diagnostics from $168.00 to $175.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st. StockNews.com ...

On Friday, Barclays (LON:BARC) made a change to its rating for Rockwoil shares, downgrading from Overweight to Equalweight while maintaining its price target at DKK3,300.00. The adjustment by the firm ...